.Clcl glycine;
WE HAVE BEEN STUDYISG nutrient absorption in the diabetic rat (6, 16, 18, 22) where wet weight of entire segment is the sum of wet weights of the portion removed for scraping and remainder of segment. Dry weight of the entire intestine is the sum of the dry weights of the proximal, mid, and distal segments. Intestinal drv weights calculated this way showed less scatter when treated statistically than those obtained from the sum of dry weights of all components, with corrections for small losses of tissue during scraping of the three lo-cm portions.
From wet and dry weight of mucosal scrapings and underlying tissue of the three segments, dry weight of mucosa was calculated as follows :
dry wt of mucosa of segment = (dry wt of mucosa of scraped portion) X (wet w t of segmcn .t> (wet wt of scraped portion)
The sum of the dry weights of mucosa of the three is the dry weight of mucosa for the entire intestine. Chromcrtogra~hy. Effluent samples from intestinal perfusion of leucine and lysine in control and diabetic rats were chromatographcd on paper. L-Leucinc was chromatographed in the butanol: acetic acid : water system described above.
Ninety-five percent of the radioactivity in the perfusion solution was in the same zone as the L-leucine standards.
In both controls and diabetics, 90-91 % of the radioactivity in the luminal effluent was at this position. L-Lysine was chromatographed in the b utanol: acetic acid: water system and in a phenol-saturated-borate buffer system (filter paper also dipped in borate buffer, pH 9.3) (20). In both systems, 92-97 % of the lysine in the perfusion solution ran at the same position as the standards. Xnety to ninety-six percent of the radioactivity in luminal effluents was recovered at the same position in both controls and diabetics.
Essentially all of the radioactivity spotted was recovered from the chromatograms. Table 1 shows groups studied and their blood glucose L data. Only diabetic rats showed glycosuria. Mean blood c glucose was much greater in diabetics than controls, but since blood was drawn after amino acid perfusion, blood glucose was elevated above fasting levels even for controls. The greatest elevation in controls was in lysine studies, consi acid. stent with the glucogen-relea sing action of this amino Table 2 presents data from 5-day and Table 3 from 7-and 12-day studies. For each group initial body weights of controls and animals to be made diabetic were closely matched. mucosal water content, 70, = wet wt of mucosa of segment) -(dry wt of mucosa of segment) X (100) (wet wt of mucosa of segment)
RESULTS
Intestinal weight (5 dclys). Comparing initial and final nonfasted body weight (measured just before fasting the rats the evening prior to perfusion), controls grew and diabetics lost weight (Table 2 ). This is true whether controls were fed ad libitum (leucine, lvsine, AIB) or were pair-fed (proline, glycine). Dry weight of total small intestine and mucosa, however, is the same in controls and diabetics, except for the small but statistically significant differences in the lysine (entire intestine) and proline (mucosa) studies (Table  2) . Leucine and lysine groups were studied during the summer and showed similar ratios of mucosa to total intestine. Proline, glycine, and AIB were studied during winter and early spring and had a somewhat lower ratio of mucosa to total intestine. The reason for the differences is not known, but possibly is a seasonal effect. Since AIB was studied first followed by leucine, lysine, glycine, and proline, these data are not readily explained as differences in technique developing during the course of the studies.
Absorption (5 days). Total absorption, i.e., absorption per animal, is greater in diabetics than controls for leucine (37 %) and lysine (28 %) ( Table  2) . Total intestinal and mucosal weights are the same in controls and diabetics in leucine studies. In lysine studies, total intestinal weight is significantly lower in diabetics than controls, although mucosal weight is the same in both. Therefore, the increase Intestinal weight (7-and IZ-day studies). On the basis of body weight, controls grew and diabetics lost weight during the 7-or 12-day interval after injection (Table 3) . Total intestinal and mucosal weight, however, was greater in the diabetic group: 20 % at 7 days (AIB study) and 40-60 % at 12 days (leucine, lysine, and AIB studies). Absorption (7-and IZ-day studies). Leucine, lysine, and AIB absorption per animal was increased in diabetics as compared with controls approximately in proportion to the increase in intestinal and mucosal dry weight. Hence, absorption per gram intestine and per gram mucosa was the same in diabetic and control animals.
Net water movement. Mean net water movement in controls was minimal, ranging from 2 % secretion to 2 % absorption in different studies. Diabetics showed net absorption, except in glycine studies where there was no net water movement. In other 5-day studies mean net water absorption in diabetics ranged from 2 to 5 %. In 12-day studies mean net water absorption tended to be greater, 9 % for leucine and AIB and 3 % for lysine. In all instances net water absorption in diabetics was significantly greater than in controls (P < 0.05).
DISCUSSION

Induction
of alloxan or streptozotocin diabetes in the rat produces initial loss of body weight followed by reduced rate of growth as indicated by lower body weights in diabetics as compared with controls at 5, 7, and 12 days after injection of the diabetogenic agent (Tables 2 and 3 ). In contrast with decreased body weight in diabetics, total 3. Seven-and twelve-day studies in controls (C) and diabetics (II): grou&, intestinal and absor@on data -.
- intestinal and mucosal dry weights are similar in both diabetics and controls at 5 days (Table 2) . By the 7th day, intestinal and mucosal dry weights are significantly greater in diabetics (20 70) than controls (Table  3 ). This greater growth rate of intestine and mucosa in diabetics continues, c and by 12 days total intestinal and mucosal dry weight is 40-60 % greater in diabetics than controls (Table 3) .
In contrast to time of onset of greater intestinal growth in diabetics, stimulation of absorption occurs earlier. Thus, absorption of leucine and lysine is increased at 5 days (Table  2 ). Since at this time mucosal dry weights are the same in controls and diabetics, stimulation of absorption reflects increased specific transport per unit of mucosa. However, there is no enhancement of absorption of proline, glycine, or a-aminoisobutyric acid (AIB) at 5 days (Table 2) . These amino acids are transported by different pathways: leucine is absorbed by the neutral, lysine by the basic, and proline, glycinc, and AIB by the imino acid-glycine pathway (1, 4, 5, 12). Thus, stimulation of specific absorption of amino acid at 5 days appears to be selective: the neutral and basic pathways are stimulated, the imino acid-glycine pathway is not.
The 1 'L-day interval was selected for study to examine the effect of the greater intestinal growth in diabetics on absorption.
At 12 days all amino acids studied showed 50 % greater absorption per animal in diabetics, which paralleled the 50 % greater mucosal weight (Table 3) . At 7 days AIB absorption and mucosal growth were both 20 %I greater in diabetics than controls. Thus, increased amino acid absorption in diabetics can also be a direct consequence of mucosal growth. This increase appears to be general and contrasts with selectivity of stimulation of specific transport per unit of mucosa at 5 days. It occurs whether or not there is prior stimulation of specific absorption. In fact, specific absorption of lcucinc and lysine, which is stimulated in diabetics at 5 days, is the same in both controls and diabetics at 12 days. The mean increase in total absorption is 50 % at 12 days, in comparison with 37 % (leucine) and 28 % (lysine) increases in total absorption at 5 days. Hence, the mucosal growthmediated increase in absorption, although requiring more time, may give greater total absorption than stimulation of specific absorption.
Diabetic rats weighed less than controls. Hence, the incre Ased absorption per animal for leucine and lysine is even greater when based on unit weight of animal. intestine is increased only at 5-8 days, but not at 70 days. Hence, there may be inherent methodological differences between findings in vivo and in vitro. Based on total radioactivity recovered from the small intestine, only 3-10 % of amino acid absorbed during the l-h study period remained as tissue radioactivity at the end of the experiment, when the intestine was removed for analysis. In vitro most of the amino acid taken up remains in intestinal tissue in everted sac studies, or absorption is measured as intestinal tissue concentration in ring and slice studies. This may explain some of the differences between in vivo and in vitro studies. However, the present in vivo studies examined absorption by the entire small intestine.
In vitro studies necessarily utilized only a small segment of small intestine. Hence, regional variations in pattern of amino acid absorption along the length of the intestine could also explain differences between in vitro and in vivo findings.
The cause for increased leucine and lysine absorption in diabetics at 5 days is unknown.
It is unlikely that the slightly greater water absorption in diabetics than controls has a significant role in the greater leucine and lysine absorption. Water absorption was also greater in diabetics for proline and AIB, but their absorption was not increased. Previous studies (13) have shown that increased protein intake increases serosal transport of L-leucine by everted sacs of rat small intestine.
In contrast, transport of L-histidine into serosal fluid by everted sacs is increased by decreasing dietary protein or by both decreasing dietary protein and adding L-histidine (10). In the latter studies, however, although controls grew, rats on experimental diets either did not grow or lost weight, and their everted segments (presumably of equal length) weighed 15-33 % less than the controls.
Hence, decreased sac wall thickness might have permitted increased entry of substrate into serosal medium. The same problem arises in interpreting significance of serosal transfer by sacs when gut wall thickness is increased through greater intestinal growth in diabetes (16). Level of protein intake per se cannot explain effects in our studies where total food and hence protein intake were decreased in diabetic rats at 5 days (7), and mucosal weights were the same: a) absorption of leucine and lysine per unit mucosa was increased in association with this decreased protein intake, b) despite greater food intake in controls than diabetics, absorption of AIB was the same in both groups at 5 days. In studies using everted rings, pair-feeding controls and diabetics was said not to affect transport (11). Hence, it is unlikely that differences in food intake play a role in determining effects at 5 days. In all 12-day studies, food intake was increased in diabetic groups. If increased food intake is responsible for increased intestinal growth in diabetics, to that extent increased total absorption per animal is dependent on greater food intake. 
